FAIR VALUE MEASUREMENTS - Schedule of Financial Assets and Liabilities (Details) - USD ($)		Dec. 31, 2021	Dec. 31, 2020
Assets, at fair value
Investments held in Trust Account		$ 1,000,284,779	$ 0
Liabilities, at fair value
Warrant liabilities	[1]	31,704,522	$ 0
Quoted Prices in Active Markets (Level 1)
Assets, at fair value
Investments held in Trust Account		1,000,284,779
Quoted Prices in Active Markets (Level 1) | Derivative Financial Instruments, Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities		17,822,000
Quoted Prices in Active Markets (Level 1) | Derivative Financial Instruments, Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities		0
Significant Other Observable Inputs (Level 2)
Assets, at fair value
Investments held in Trust Account		0
Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities		0
Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities		0
Significant Other Unobservable Inputs (Level 3)
Assets, at fair value
Investments held in Trust Account		0
Significant Other Unobservable Inputs (Level 3) | Derivative Financial Instruments, Liabilities | Public Warrants
Liabilities, at fair value
Warrant liabilities		0
Significant Other Unobservable Inputs (Level 3) | Derivative Financial Instruments, Liabilities | Private Placement Warrants
Liabilities, at fair value
Warrant liabilities		$ 13,882,522

[1] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amount as of December 31, 2020 has been retroactively restated to account for the share recapitalization events as discussed in Note 4.